Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 4.8B | 4.9B | 4.6B |
Cost of revenue | 3.8B | 3.6B | 3.5B | 3.3B |
Gross profit | 1.6B | 1.3B | 1.4B | 1.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 257.9M | 247.6M | 215.3M | 290.3M |
Operating income | 985.4M | 676.1M | 802.3M | 632.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 41.6M | 55.2M | 48.1M | 40.7M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 755.0M | 903.2M | 724.1M |
Tax provision | 278.8M | 190.5M | 229.4M | 201.9M |
Net income | 802.1M | 564.5M | 673.8M | 522.1M |
Basic EPS | — | 12.9 | 15.4 | 12.0 |
Diluted EPS | — | 12.9 | 15.4 | 12.0 |
Basic average shares | — | 43.7M | 43.6M | 43.7M |
Diluted average shares | — | 43.7M | 43.6M | 43.7M |
EBITDA | 1.3B | 967.6M | 1.1B | 924.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | 110K | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |